Gene therapy for erectile dysfunction: What is the future?

Arnold Melman, Kelvin Davies

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations


Gene transfer for the treatment of erectile dysfunction has completed phase 1 safety testing and has shown the necessary safety to proceed to the next level of clinical trial. This review focuses on the background of the components of that have led to US Food and Drug Administration acceptance of human gene transfer trials for nonlethal disease.

Original languageEnglish (US)
Pages (from-to)421-426
Number of pages6
JournalCurrent urology reports
Issue number6
StatePublished - Nov 2010


  • Corpora cavernous
  • Erectile dysfunction
  • Gene transfer
  • Naked DNA, Overactive bladder
  • Phase I trial
  • Plasmid
  • Smooth muscle

ASJC Scopus subject areas

  • Urology


Dive into the research topics of 'Gene therapy for erectile dysfunction: What is the future?'. Together they form a unique fingerprint.

Cite this